Amgen

Amgen is one of the largest pure-play biotechs by revenue, with an established portfolio spanning oncology, cardiovascular disease, inflammation, and bone health, plus a growing obesity and metabolic disease pipeline following recent pipeline bets. That scale means Amgen trains people across the full commercialization lifecycle, not just discovery.

Recruits Lab sees strong demand for Amgen alumni in biologics manufacturing and biostatistics because Amgen runs one of the industry's largest internal manufacturing networks, including its Thousand Oaks and Rhode Island sites. That operational depth is rarer at younger biotechs and commands a premium when a growth-stage company is preparing for its first commercial launch.

Amgen organizes R&D through Research, Global Development, and Global Product Operations with clear title ladders: Scientist through Senior Principal Scientist in discovery, Executive Director and Vice President in Global Development for late-stage programs, and a large Biostatistics and Bioinformatics organization with its own Director and Senior Director track.

Manufacturing and CMC run through Process Development and Global Supply Chain, with titles like Director of Drug Substance and Senior Director of Manufacturing Science and Technology. Commercially, Amgen's Marketing and Market Access functions carry weight because of its large payer-negotiation experience, an underrated skill set for biotechs approaching launch.

Amgen's process leans heavily on structured competency interviews layered on top of technical assessment, reflecting its large-company HR infrastructure. Expect a recruiter screen, hiring manager interview, and a panel round that includes cross-functional stakeholders, often with a formal case or data-presentation component for scientific and biostatistics roles.

Amgen has historically hired for long tenure and internal progression, so interviewers probe for evidence a candidate can operate inside a matrixed global organization, not just execute a narrow technical task.

The strongest big-pharma-to-biotech-startup move out of Amgen is a Director or Senior Director in Manufacturing Science stepping into a Head of CMC role at a biotech approaching its first BLA. These candidates bring process knowledge that is hard to build in-house quickly, and the startup gets years of scaled-manufacturing pattern recognition in one hire.

Motivators: title and scope expansion, since Amgen's flatter growth at senior levels means fewer VP openings than the bench of qualified directors waiting for them. Blockers: strong retirement and long-term incentive vesting schedules that penalize early departure, plus genuine loyalty built through internal mobility programs.

Amgen's Thousand Oaks headquarters anchors a large in-person workforce; candidates based there are often open to Bay Area, Boston, or remote biotech roles but expect relocation support. Counter-offers commonly include accelerated promotion timelines rather than pure cash increases, so recruiters should lead with scope and equity upside, not just base salary.